247 related articles for article (PubMed ID: 10896355)
1. The role of carbonic anhydrase inhibitors in the management of macular edema.
Wolfensberger TJ
Doc Ophthalmol; 1999; 97(3-4):387-97. PubMed ID: 10896355
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of membrane-bound carbonic anhydrase decreases subretinal pH and volume.
Wolfensberger TJ; Dmitriev AV; Govardovskii VI
Doc Ophthalmol; 1999; 97(3-4):261-71. PubMed ID: 10896339
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of membrane-bound carbonic anhydrase enhances subretinal fluid absorption and retinal adhesiveness.
Wolfensberger TJ; Chiang RK; Takeuchi A; Marmor MF
Graefes Arch Clin Exp Ophthalmol; 2000 Jan; 238(1):76-80. PubMed ID: 10664057
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa.
Grover S; Fishman GA; Fiscella RG; Adelman AE
Retina; 1997; 17(3):222-31. PubMed ID: 9196934
[TBL] [Abstract][Full Text] [Related]
5. Retrospective cohort study exploring whether an association exists between spatial distribution of cystoid spaces in cystoid macular oedema secondary to retinitis pigmentosa and response to treatment with carbonic anhydrase inhibitors.
Strong SA; Hirji N; Quartilho A; Kalitzeos A; Michaelides M
Br J Ophthalmol; 2019 Feb; 103(2):233-237. PubMed ID: 29706600
[TBL] [Abstract][Full Text] [Related]
6. Membrane-bound carbonic anhydrase in human retinal pigment epithelium.
Wolfensberger TJ; Mahieu I; Jarvis-Evans J; Boulton M; Carter ND; Nógrádi A; Hollande E; Bird AC
Invest Ophthalmol Vis Sci; 1994 Aug; 35(9):3401-7. PubMed ID: 8056514
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and prognostic factors of response to carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa.
Liew G; Moore AT; Webster AR; Michaelides M
Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1531-6. PubMed ID: 25670491
[TBL] [Abstract][Full Text] [Related]
8. [Cystoid macular edema in uveitis].
Thurau SR
Ophthalmologe; 2005 May; 102(5):485-90. PubMed ID: 15747121
[TBL] [Abstract][Full Text] [Related]
9. The effect of oral acetazolamide on cystoid macular edema in hydroxychloroquine retinopathy: a case report.
Hong EH; Ahn SJ; Lim HW; Lee BR
BMC Ophthalmol; 2017 Jul; 17(1):124. PubMed ID: 28701214
[TBL] [Abstract][Full Text] [Related]
10. The effect of acetazolamide on passive and active transport of fluorescein across the blood-retina barrier in retinitis pigmentosa complicated by macular oedema.
Moldow B; Sander B; Larsen M; Engler C; Li B; Rosenberg T; Lund-Andersen H
Graefes Arch Clin Exp Ophthalmol; 1998 Dec; 236(12):881-9. PubMed ID: 9865617
[TBL] [Abstract][Full Text] [Related]
11. Carbonic Anhydrase Inhibitor with Topical NSAID Therapy to Manage Cystoid Macular Edema in a Case of Gyrate Atrophy.
Piozzi E; Alessi S; Santambrogio S; Cillino G; Mazza M; Iggui A; Cillino S
Eur J Ophthalmol; 2017 Nov; 27(6):e179-e183. PubMed ID: 28708224
[TBL] [Abstract][Full Text] [Related]
12. A randomized, masked, cross-over trial of acetazolamide for cystoid macular edema in patients with uveitis.
Whitcup SM; Csaky KG; Podgor MJ; Chew EY; Perry CH; Nussenblatt RB
Ophthalmology; 1996 Jul; 103(7):1054-62; discussion 1062-3. PubMed ID: 8684794
[TBL] [Abstract][Full Text] [Related]
13. Treatment of cystoid macular edema with acetazolamide in a patient with serpiginous choroidopathy.
Steinmetz RL; Fitzke FW; Bird AC
Retina; 1991; 11(4):412-5. PubMed ID: 1813958
[TBL] [Abstract][Full Text] [Related]
14. [Therapy of cystoid diffuse macular edema after uveitis and cataract surgery with the carbonic anhydrase inhibitor acetazolamide (Diamox)].
Schilling H; Pauleikhoff D; Schrenk M; Wessing A
Klin Monbl Augenheilkd; 1993 Mar; 202(3):206-11. PubMed ID: 8510414
[TBL] [Abstract][Full Text] [Related]
15. Long-term effect of acetazolamide treatment of patients with uveitic chronic cystoid macular edema is limited by persisting inflammation.
Schilling H; Heiligenhaus A; Laube T; Bornfeld N; Jurklies B
Retina; 2005; 25(2):182-8. PubMed ID: 15689809
[TBL] [Abstract][Full Text] [Related]
16. POSSIBLE EFFICACY OF TOPICAL DORZOLAMIDE IN THE TREATMENT OF PACLITAXEL-RELATED CYSTOID MACULAR EDEMA.
Dwivedi R; Tiroumal S
Retin Cases Brief Rep; 2018 Winter; 12(1):75-79. PubMed ID: 27749791
[TBL] [Abstract][Full Text] [Related]
17. Optical coherence tomography in the diagnosis and monitoring of cystoid macular edema in patients with retinitis pigmentosa.
Chung H; Hwang JU; Kim JG; Yoon YH
Retina; 2006 Oct; 26(8):922-7. PubMed ID: 17031294
[TBL] [Abstract][Full Text] [Related]
18. Retinitis pigmentosa and other dystrophies.
Sahel J; Bonnel S; Mrejen S; Paques M
Dev Ophthalmol; 2010; 47():160-167. PubMed ID: 20703049
[TBL] [Abstract][Full Text] [Related]
19. Rebound of cystoid macular edema with continued use of acetazolamide in patients with retinitis pigmentosa.
Apushkin MA; Fishman GA; Grover S; Janowicz MJ
Retina; 2007 Oct; 27(8):1112-8. PubMed ID: 18040255
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa: A meta-analysis.
Huang Q; Chen R; Lin X; Xiang Z
PLoS One; 2017; 12(10):e0186180. PubMed ID: 29023491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
